Chicago Partners Investment Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
3,115
-395
| -11% | -$34.7K | 0.01% | 888 |
|
|
2025
Q1 | $227K | Sell |
3,510
-186
| -5% | -$12K | 0.01% | 807 |
|
|
2024
Q4 | $214K | Sell |
3,696
-1,029
| -22% | -$59.5K | 0.01% | 794 |
|
|
2024
Q3 | $232K | Sell |
4,725
-72
| -2% | -$3.53K | 0.01% | 707 |
|
|
2024
Q2 | $229K | Sell |
4,797
-648
| -12% | -$30.9K | 0.01% | 680 |
|
|
2024
Q1 | $218K | Buy |
+5,445
| New | +$218K | 0.01% | 672 |
|
|
2022
Q3 | – | Sell |
-12,821
| Closed | -$162K | – | 622 |
|
|
2022
Q2 | $162K | Buy |
12,821
+423
| +3% | +$5.35K | 0.01% | 557 |
|
|
2022
Q1 | $39K | Buy |
+12,398
| New | +$39K | ﹤0.01% | 555 |
|
|
2021
Q1 | – | Sell |
-6,253
| Closed | -$247K | – | 530 |
|
|
2020
Q4 | $247K | Buy |
+6,253
| New | +$247K | 0.02% | 400 |
|